Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page or call 1-877-436-3683.

Now Approved

Now Approved

The FDA recently granted approval to our cancer immunotherapy for certain types of early non-small cell lung cancer.